# The MagnaSafe-2 Registry: Assessing the Risks of Magnetic Resonance Imaging in Three Patient Groups

> **NCT07189728** · — · NOT_YET_RECRUITING · sponsor: **The Scripps Research Institute** · enrollment: 1500 (estimated)

## Conditions studied

- Pacemakers
- MRI Imaging
- Implantable Cardioverter Defibrillator (ICD)

## Interventions

- **DIAGNOSTIC_TEST:** MRI

## Key facts

- **NCT ID:** NCT07189728
- **Lead sponsor:** The Scripps Research Institute
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-01-01
- **Primary completion:** 2031-01-01
- **Final completion:** 2031-01-01
- **Target enrollment:** 1500 (ESTIMATED)
- **Last updated:** 2025-09-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07189728

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07189728, "The MagnaSafe-2 Registry: Assessing the Risks of Magnetic Resonance Imaging in Three Patient Groups". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07189728. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*